Novoron Bioscience's Unattributed VC Round

Novoron Bioscience raised a round of funding on February 27, 2018. Investors include Backstage Capital.

Novoron Bioscience is a biotechnology company that develops pharmaceutical therapies to regenerate nerves of the central nervous system (CNS).…

Articles about Novoron Bioscience's Unattributed VC Round: